LFMD: יחס שווי שוק להכנסות LifeMD, Inc.

LifeMD, Inc. (LFMD) is developing a D2C ecosystem based on a subscription model, acquiring customers via the GLP-1 trend. On GURU.Markets, the company's current P/S ratio reflects the market valuation of its revenue, where 0.40 determines this specific parameter level. The business is implementing a digital patient journey that eliminates clinic visits, leveraging cloud-based R&D platforms and AI diagnostics to personalize medicine.

The active expansion of the LifeMD, Inc. (LFMD) telemedicine platform and the launch of weight loss programs make the company a candidate for valuation based on generated revenue. The price-to-sales ratio allows for a comparison of market capitalization against actual cash flow, where an increasing multiple signals confidence in management's strategy, while a decrease indicates an asset overvaluation, as clearly reflected by the historical P/S.